Moody’s analysts affirmed the debt ratings on Quorum Sept. 23, and changed the outlook for the for-profit company from stable to negative.
The agency said the affirmations of the ratings were based on Moody’s expectation that Quorum’s earnings will strengthen over the next year.
However, Moody’s said it believes “that the magnitude of earnings improvement will be highly contingent on the successful execution of both divestiture efforts and plans to augment its revenue cycle management.”
Quorum announced in May that it is outsourcing RCM services to R1 RCM, and anticipates a $50 million annual boost from the deal by 2021. The company, a spinoff of Franklin, Tenn.-based Community Health Systems, also revealed plans to continue selling off hospitals.
Moody’s said Quorum’s new outlook is based on the high risk associated with execution of its divestiture efforts and revenue cycle plans as well as “rising refinancing risk if these initiatives do not begin to take hold over the next six to nine months.”
“Failure to show significant improvement in earnings over the next several quarters will likely result in a downgrade,” the agency added.
Read the full Moody’s report here.
More articles on healthcare finance:
M&A may bring long-term benefit for nonprofit hospitals, Fitch says
SSM Health to transfer billing operations in Wisconsin
Hospitals slam CMS proposal to disclose negotiated rates
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
